Zydus Lifesciences Gains 0.34%: 4 Key Factors Driving This Week’s Mixed Momentum
2026-11-22 11:00:08Key Events This Week 16 Nov: Technical momentum shifts amid mixed indicator signals 18 Nov: Significant open interest surge in derivatives 18 Nov: Technical momentum upgrades to bullish trend 18 Nov: Valuation grade upgraded to attractive 20 Nov: Week closes at ₹1,195.05 (+0.34%) Week Open₹1,189.00 <div ...
Read More
Zydus Lifesciences Ltd is Rated Hold by MarketsMOJO
2026-11-20 10:11:27Zydus Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Zydus Lifesciences Sees Significant Open Interest Surge Amid Mixed Market Signals
2026-11-18 15:00:12Zydus Lifesciences Ltd has witnessed a notable 10.65% increase in open interest in its derivatives segment, signalling heightened market activity despite a marginal decline in its share price. This surge in open interest, coupled with volume and positioning data, offers valuable insights into investor sentiment and potential directional bets in the pharmaceutical mid-cap stock.
Read More
Zydus Lifesciences Ltd Valuation Shifts Signal Renewed Price Attractiveness
2026-11-18 08:01:10Zydus Lifesciences Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, signalling improved price appeal for investors. This change comes amid a backdrop of mixed valuations across the Pharmaceuticals & Biotechnology sector, with Zydus now standing out for its relative affordability and solid financial metrics.
Read More
Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-11-18 08:01:07Zydus Lifesciences Ltd has exhibited a notable shift in technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of moving averages, MACD, and Bollinger Bands signals, suggesting a strengthening price momentum amid a robust market backdrop.
Read More
Zydus Lifesciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-11-16 08:00:53Zydus Lifesciences Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early November 2026. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the pharmaceutical and biotechnology company continues to demonstrate resilience with a year-to-date return of 30.2%, significantly outperforming the Sensex’s negative 4.3% over the same period.
Read More
Zydus Lifesciences Ltd Technical Momentum Shifts to Bullish Amid Strong Long-Term Returns
2026-11-13 08:01:25Zydus Lifesciences Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is supported by a confluence of technical indicators including MACD, moving averages, and Bollinger Bands, suggesting a strengthening price momentum amid a mid-cap pharmaceutical sector backdrop.
Read More
Zydus Lifesciences Ltd is Rated Hold by MarketsMOJO
2026-11-09 10:10:22Zydus Lifesciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 November 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read MoreZydus Lifesciences Falls 3.94%: 5 Key Factors Behind the Weekly Decline
2026-11-08 10:01:05Key Events This Week 2 Nov: New 52-week high at Rs.1,259.1 3 Nov: Further 52-week high at Rs.1,264.2 with bullish technical momentum 4 Nov: New 52-week high at Rs.1,264.4 followed by sharp open interest surge 5 Nov: Mixed Q3 results with strong revenue growth but profitability challenges 6 Nov: Week closes at Rs.1,195.00, down 0.12% on the day Week OpenRs.1,...
Read MoreAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
14-Nov-2026 | Source : BSEPress Release
Announcement under Regulation 30 (LODR)-Updates on Joint Venture
12-Nov-2026 | Source : BSECompletion of transaction
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
07-Nov-2026 | Source : BSETranscript of the post results earnings call held on November 4 2026.
Corporate Actions
No Upcoming Board Meetings
Zydus Lifesciences Ltd has declared 100% dividend, ex-date: 24 Jul 26
Zydus Lifesciences Ltd has announced 1:5 stock split, ex-date: 06 Oct 15
Zydus Lifesciences Ltd has announced 1:2 bonus issue, ex-date: 05 Apr 10
No Rights history available